AAAAAA
Results:
1-20
|
Results: 20
Authors:
Invernizzi, R
Pecci, A
Bellotti, L
Ascari, E
Citation: R. Invernizzi et al., Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes, LEUK LYMPH, 42(3), 2001, pp. 481-489
Authors:
Perfetti, V
Vignarelli, MC
Casarini, S
Ascari, E
Merlini, G
Citation: V. Perfetti et al., Biological features of the clone involved in primary amyloidosis (AL), LEUKEMIA, 15(2), 2001, pp. 195-202
Authors:
Gobbi, PG
Ghirardelli, ML
Solcia, M
Di Giulio, G
Merli, F
Tavecchia, L
Berte, R
Davini, O
Levis, A
Broglia, C
Maffe, GC
Ilariucci, F
Dore, R
Ascari, E
Citation: Pg. Gobbi et al., Image-aided estimate of tumor burden in Hodgkin's disease: Evidence of itsprimary prognostic importance, J CL ONCOL, 19(5), 2001, pp. 1388-1394
Authors:
Gobbi, PG
Broglia, C
Broglia, F
Ascari, E
Citation: Pg. Gobbi et al., Designing clinical trials on gastric lymphomas and reporting outcomes, HAEMATOLOG, 86(8), 2001, pp. 785-790
Authors:
Gobbi, PG
Zinzani, PL
Broglia, C
Comelli, M
Magagnoli, M
Federico, M
Merli, F
Iannitto, E
Tura, S
Ascari, E
Citation: Pg. Gobbi et al., Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems, CANCER, 91(8), 2001, pp. 1467-1478
Authors:
Palladini, G
Anesi, E
Perfetti, V
Obici, L
Invernizzi, R
Balduini, C
Ascari, E
Merlini, G
Citation: G. Palladini et al., A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis, BR J HAEM, 113(4), 2001, pp. 1044-1046
Authors:
Danova, M
Porta, C
Ferrari, S
Brugnatelli, S
Comolli, G
Riccardi, A
Ascari, E
Citation: M. Danova et al., Cell cycle status and apoptosis of hematopoietic progenitor cells releasedinto the peripheral blood after taxanes and granulocyte colony-stimulatingfactor in breast cancer patients, ONCOL REP, 7(3), 2000, pp. 585-589
Authors:
Gobbi, PG
Broglia, C
Berte, R
Petrilli, MP
Molica, S
Angrilli, F
Iannitto, E
Ghirardelli, ML
Di Renzo, N
Cavanna, L
Ascari, E
Citation: Pg. Gobbi et al., Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 722-728
Authors:
Pugliese, P
Danova, M
Brugnatelli, S
Piccolo, G
Riccardi, A
Ascari, E
Citation: P. Pugliese et al., Acute rhabdomyolysis after high-dose chemotherapy and circulating progenitor cell autografting for breast cancer, HAEMATOLOG, 85(6), 2000, pp. 672-672
Authors:
Gobbi, PG
Ghirardelli, ML
Cavalli, C
Baldini, L
Broglia, C
Clo, V
Berte, R
Ilariucci, F
Carotenuto, M
Piccinini, L
Stelitano, C
Attardo-Parrinello, G
Ascari, E
Citation: Pg. Gobbi et al., The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas, HAEMATOLOG, 85(4), 2000, pp. 372-380
Authors:
Gobbi, PG
Ghirardelli, ML
Avanzini, P
Baldini, L
Quarta, G
Stelitano, C
Broglia, C
Loni, C
Silingardi, V
Ascari, E
Citation: Pg. Gobbi et al., A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL), HAEMATOLOG, 85(3), 2000, pp. 263-268
Authors:
Riccardi, A
Mora, O
Tinelli, C
Valentini, D
Brugnatelli, S
Spanedda, R
De Paoli, A
Barbarano, L
Di Stasi, M
Giordano, M
Delfini, C
Nicoletti, G
Bergonzi, C
Rinaldi, E
Piccinini, L
Ascari, E
Citation: A. Riccardi et al., Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study, BR J CANC, 82(7), 2000, pp. 1254-1260
Authors:
Ferrari, S
Danova, M
Porta, C
Comolli, G
Brugnatelli, S
Pugliese, P
Riccardi, A
Ascari, E
Citation: S. Ferrari et al., Circulating progenitor cell release and functional characterization after Topotecan plus G-CSF and erythropoietin in small cell lung cancer patients, INT J ONCOL, 15(4), 1999, pp. 811-815
Authors:
Perfetti, V
Vignarelli, MC
Anesi, E
Garini, P
Quaglini, S
Ascari, E
Merlini, G
Citation: V. Perfetti et al., The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients, HAEMATOLOG, 84(3), 1999, pp. 218-221
Authors:
Sitar, G
Balduini, CL
Manenti, L
Castello, A
Balanzin, D
Ascari, E
Citation: G. Sitar et al., Possible evolution of human parvovirus B19 infection into erythroleukemia, HAEMATOLOG, 84(10), 1999, pp. 957-959
Authors:
Balduini, CL
Guarnone, R
Pecci, A
Centenara, E
Invernizzi, R
Ascari, E
Citation: Cl. Balduini et al., The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution, HAEMATOLOG, 84(1), 1999, pp. 12-16
Authors:
Sitar, G
Garagna, S
Zuccotti, M
Falcinelli, C
Montanari, L
Alfei, A
Ippoliti, G
Redi, CA
Moratti, R
Ascari, E
Forabosco, A
Citation: G. Sitar et al., Fetal erythroblast isolation up to purity from cord blood and their culture in vitro, CYTOMETRY, 35(4), 1999, pp. 337-345
Authors:
Porta, C
Danova, M
Riccardi, A
Bobbio-Pallavicini, E
Ascari, E
Citation: C. Porta et al., Cancer chemotherapy-related thrombotic thrombocytopenic purpura: Biological evidence of increased nitric oxide production, MAYO CLIN P, 74(6), 1999, pp. 570-574
Authors:
Merlini, G
Anesi, E
Garini, P
Perfetti, V
Obici, L
Ascari, E
Lechuga, MJ
Capri, G
Gianni, L
Citation: G. Merlini et al., Treatment of AL amyloidosis with 4 '-iodo-4 '-deoxydoxorubicin: An update, BLOOD, 93(3), 1999, pp. 1112-1113
Authors:
Riccardi, A
Brugnatelli, S
Giordano, M
Danova, M
Pugliese, P
Tinelli, C
Klersy, C
Richetti, A
Fava, S
Nastasi, G
Rinaldi, E
Fregoni, V
De Monte, A
Trotti, G
Bovio, A
Ascari, E
Citation: A. Riccardi et al., Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer, TUMORI, 84(5), 1998, pp. 540-546
Risultati:
1-20
|